Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM)

被引:20
作者
Urrutia-Rojas, X
Menchaca, J
Wadley, W
Ahmad, N
Lacko, A
Bae, S
Spellman, C
Kudchodkar, B
Kudolo, G
McConathy, W
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Med, Ft Worth, TX 76107 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Cooks Childrens Phys Network, Ft Worth, TX USA
关键词
Acanthosis nigricans; body mass index; metabolic syndrome; prediabetic;
D O I
10.1016/j.jadohealth.2003.07.005
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Purpose: To assess risk factors for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) with the hypothesis that risk for T2DM in children would be associated with an increase in risk factors for CVD. Methods: Subjects from a group of Mexican-American school children (aged 10-12 years) identified to be at risk for T2DM, and their siblings, were selected for this study. There were 68 children with acanthosis nigricans (AN+), and 71 without AN (AN-). Both AN+ and AN-children were assessed for T2DM and CVD risk factors. Probands and siblings were evaluated by physical examination, family history, and fasting serum parameters: glucose, insulin, body mass index (BMI), serum lipoproteins, and oxidized lipids. Data were analyzed by descriptive, univariate, and multivariate procedures. Results: BMI, waist/hip ratio, systolic and diastolic blood pressure were all significantly higher (p < .002) in AN+, whereas Tanner stages were similar in both groups. Fasting serum glucose was in the normal range, whereas insulin was elevated in AN+ compared with AN - (30.0 +/- 1.9 muU/ml, vs. 14.8 +/- 1.0 p < .0001). Insulin resistance as assessed by the homeostasis assessment model (HOMA-IR) was elevated in both groups, although higher among AN+ (p < .0001). High-density lipoprotein-cholesterol (HDL-C) was lower (6.2 mg/dL) in the AN+ group (p < .003). The lower HDL-C in AN+ was associated with elevated triglycerides and a higher serum total cholesterol TC/HDL-C ratio when contrasted with the AN- values (145.9 +/- 7.6 mg/dL vs. 97.1 +/- 0.07, p < .0001; 4.1 +/- 0.2 vs. 3.4 +/- 0.1, p < .0001, respectively). In addition to the high prevalence of overweight/obesity (BMI > 85th percentile) in this population (76.3%, 106/ 139), elevated insulin (59.7% >15 muU/mL), low HDL-C (27.3% < 40 mg/dL), and elevated low-density lipoprotein cholesterol (LDL-C) (41.0% > 100 mg/dL) were also detected. Conclusions: The altered metabolic pattern observed in this group of Mexican-American children is characteristic of metabolic syndrome, a condition associated with obesity and increased risk for both T2DM and CVD in adults. This study points to the value of BMI and acanthosis nigricans as easily accessible markers for children and nuclear families at increased risk for developing T2DM and CVD. (C) Society for Adolescent Medicine, 2004
引用
收藏
页码:290 / 299
页数:10
相关论文
共 44 条
[1]  
[Anonymous], 2000, Pediatrics, V105, P671
[2]   TYPE 2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS, HYPERTENSION AND HYPERLIPEMIA (SYNDROME-X) - RELATION TO REDUCED FETAL GROWTH [J].
BARKER, DJP ;
HALES, CN ;
FALL, CHD ;
OSMOND, C ;
PHIPPS, K ;
CLARK, PMS .
DIABETOLOGIA, 1993, 36 (01) :62-67
[3]  
Berenson G S, 2001, Prev Cardiol, V4, P116, DOI 10.1111/j.1520-037X.2001.00537.x
[4]   Precursors of cardiovascular risk in young adults from a biracial (black-white) population: The Bogalusa Heart Study [J].
Berenson, GS ;
Srinivasan, SR ;
Bao, WH .
ADOLESCENT NUTRITIONAL DISORDERS: PREVENTION AND TREATMENT, 1997, 817 :189-198
[5]   A quantitative scale of acanthosis nigricans [J].
Burke, JP ;
Hale, DE ;
Hazuda, HP ;
Stern, MP .
DIABETES CARE, 1999, 22 (10) :1655-1659
[6]  
Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0
[7]   Age-belated patterns of the clustering of cardiovascular risk variables of Syndrome X from childhood to young adulthood in a population made up of black and white subjects - The Bogalusa Heart Study [J].
Chen, W ;
Bao, WH ;
Begum, S ;
Elkasabany, A ;
Srinivasan, SR ;
Berenson, GS .
DIABETES, 2000, 49 (06) :1042-1048
[8]  
Chen W, 1999, AM J EPIDEMIOL, V150, P667
[9]  
CLARK D, 1998, REVISED CDC NCHS GRO
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497